185909-02-8 Usage
General Description
1-(4-phenoxyphenyl)pentan-1-amine is a chemical compound with the molecular formula C17H23NO. It is a member of the amine class of compounds and consists of a pentylamine group attached to a phenyl ring with a phenoxy group attached to the para position of the first phenyl ring. 1-(4-phenoxyphenyl)pentan-1-amine has a wide range of applications, including as a building block in the synthesis of various pharmaceuticals and agrochemicals. It is also used in the production of certain polymers and as a precursor in the creation of advanced materials. Additionally, it may have potential therapeutic uses due to its interactions with various biological systems and targets.
Check Digit Verification of cas no
The CAS Registry Mumber 185909-02-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,9,0 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 185909-02:
(8*1)+(7*8)+(6*5)+(5*9)+(4*0)+(3*9)+(2*0)+(1*2)=168
168 % 10 = 8
So 185909-02-8 is a valid CAS Registry Number.
185909-02-8Relevant articles and documents
BISPHENYL INHIBITORS OF FARNESYLPROTEIN TRANSFERASE
-
, (2008/06/13)
The present invention comprises peptidomimetic compounds which comprise a suitably substituted aminoalkylbenzene and analine analogs, further substituted with a second phenyl ring attached via a bond, a heteroatom linker or an aliphatic linker. The instant compounds inhibit the farnesyl-protein transferase enzyme and the farnesylation of certain proteins. Furthermore, the instant farnesyl protein transferase inhibitors differ from those previously described as inhibitors of farnesyl-protein transferase in that they do not have a thiol moiety. The lack of the thiol offers unique advantages in terms of improved pharmacokinetic behavior in animals, prevention of thiol-dependent chemical reactions, such as rapid autoxidation and disulfide formation with endogenous thiols, and reduced systemic toxicity. Further contained in this invention are chemotherapeutic compositions containing these farnesyl transferase inhibitors and methods for their production
